...
首页> 外文期刊>Clinical Endocrinology >Molecular analysis of the PAX8 gene in a sample of Mexican patients with primary congenital hypothyroidism: identification of the recurrent p.Arg31His mutation.
【24h】

Molecular analysis of the PAX8 gene in a sample of Mexican patients with primary congenital hypothyroidism: identification of the recurrent p.Arg31His mutation.

机译:墨西哥原发性先天性甲状腺功能减退症患者样本中PAX8基因的分子分析:p.Arg31His复发突变的鉴定。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The Mexican population has one of the highest recorded incidences of primary congenital hypothyroidism (CH) in the world (i.e. 8-3/10 000 live births in South-east Mexico). However, it is not known whether mutations in genes involved in thyroid gland development, such as PAX8 (paired box gene 8), contribute to this high frequency of CH. The aim of this study was to ascertain whether mutations in the PAX8 gene are associated with CH in 100 sporadic and unrelated patients of Mexican origin detected through neonatal TSH (thyroid-stimulating hormone) screening and with a confirmed diagnosis of permanent primary CH. In most cases (n = 96), the diagnosis of thyroid dysgenesis (TD) was established by ~(99m)Tc scintigraphy. In each patient, the entire PAX8 coding sequence (RefSeq NM_ 003466.3), including exon-intron boundaries, was analysed by single-stranded conformation polymorphism analysis and direct sequencing. Potential deleterious splicing effects caused by disruption of exonic splicing enhancers (ESEs) were established by assessing all silent and unreported exonic variations identified in CH cases using ESEfinder ver. 3.0 software (http://rulai.cshl.edu/ cgi-bin/tools/ESE3/esefinder.cgi?process=home). The unreported variations in the PAX8 gene were tested in DNA samples of 200 healthy Mexican individuals.
机译:墨西哥人口是世界上原发性先天性甲状腺功能减退症(CH)发生率最高的记录之一(即墨西哥东南部8-3 / 10 000例活产)。但是,尚不清楚参与甲状腺发育的基因中的突变,例如PAX8(配对盒基因8)是否促成这种高频率的CH。这项研究的目的是确定通过新生儿TSH(甲状腺刺激激素)筛查发现的100例散发性和非相关性墨西哥裔患者中,PAX8基因突变是否与CH相关,并确诊为永久性原发性CH。在大多数情况下(n = 96),通过〜(99m)Tc闪烁显像技术可确定甲状腺发育不全(TD)的诊断。在每位患者中,通过单链构象多态性分析和直接测序分析了包括外显子-内含子边界在内的整个PAX8编码序列(RefSeq NM_ 003466.3)。通过使用ESEfinder ver。评估在CH病例中鉴定出的所有沉默和未报告的外显子变异,可以确定由外显子拼接增强子(ESE)破坏引起的潜在有害剪接作用。 3.0软件(http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home)。在200名健康墨西哥人的DNA样本中测试了PAX8基因的未报告变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号